Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

Abstract Purpose Patients with unresectable dedifferentiated liposarcoma (DDLPS) have poor overall outcomes. Few genomic alterations have been identified with limited therapeutic options. Experimental Design Patients treated at Levine Cancer Institute with DDLPS were identified. Next generation sequ...

Full description

Bibliographic Details
Main Authors: Megan H. Jagosky, Colin J. Anderson, James T. Symanowski, Nury M. Steuerwald, Carol J. Farhangfar, Emily A. Baldrige, Jennifer H. Benbow, Michael B. Livingston, Joshua C. Patt, Will A. Ahrens, Jeffrey S. Kneisl, Edward S. Kim
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Cancer Medicine
Subjects:
liposarcoma
next‐generation sequencing
NGS
precision oncology
targeted therapy
Online Access:https://doi.org/10.1002/cam4.5502

Similar Items

Similar Items